Sort   by:  
 Page size 
UnknownReduction of anterior uveitis flares in patients with axial spondyloarthritis on certolizumab pegol treatment: final 2-year results from the multicenter phase IV C-VIEW study.
Not available
S-EPMC8010825 | biostudies-literature
UnknownFc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors.
Not available
S-EPMC5437702 | biostudies-literature
TranscriptomicsIntegrated genomic profiling of endometrial carcinoma
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation Although 75% of endometrial cancers are treated at an early stage, 15% to 20% of these recur. We performed an integrated analysis of genome-wide expression and copy-number dat...
ORGANISM(S): Homo sapiens 
2009-03-23 | E-GEOD-14860 | biostudies-arrayexpress
UnknownIntegrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation.
Not available
S-EPMC2660768 | biostudies-literature
UnknownAssessing the significance of chromosomal aberrations in cancer: methodology and application to glioma.
Not available
S-EPMC2148413 | biostudies-literature
UnknownEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
Not available
S-EPMC5021525 | biostudies-literature
ProteomicsStructure of an essential inner membrane protein-LPS complex identifies a novel anti-microbial peptide
Lipopolysaccharide (LPS) resides in the outer membrane (OM) of Gram-negative bacteria where it is responsible for barrier function and immune modulation. LPS is the target of polymyxins, last-resort antibiotics whose clinical use is threatened by increasing resistance. Steps in LPS biogenesis are ...
ORGANISM(S): Escherichia Coli K-12 (ncbitaxon:83333) 
2019-05-08 | MSV000083754 | MassIVE
UnknownEpidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain.
Not available
S-EPMC1702556 | biostudies-literature
UnknownCOT drives resistance to RAF inhibition through MAP kinase pathway reactivation.
Not available
S-EPMC3058384 | biostudies-literature
UnknownA restricted spectrum of missense KMT2D variants cause a multiple malformations disorder distinct from Kabuki syndrome.
Not available
S-EPMC7200597 | biostudies-literature
Sort   by:  
 Page size